MedPath

Nanoscope Cost Analysis Study

Not Applicable
Not yet recruiting
Conditions
Meniscal Tear
Interventions
Device: Arthrex Nanoscope
Device: Conventional Arthroscopy without Arthrex Nanoscope
Registration Number
NCT06603740
Lead Sponsor
Arthrex, Inc.
Brief Summary

The study is a pilot study designed to generate preliminary data regarding the cost of partial meniscectomy using NanoScope versus conventional arthroscopy in a traditional operating room (OR) setting

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  1. Subject requires simple partial posterior or mid-body meniscectomy.
  2. Subject is 18 - 60 years of age.
  3. Subject body mass index (BMI) is 35 or lower (BMI ≤ 35).
  4. Subject signed informed consent and is willing and able to comply with all study requirements and follow-up visits.
  5. Confirmed meniscal injury by physical exam as per standard of care.
  6. Normal mechanical alignment; < 5° varus and < 7° valgus, of the affected knee by clinical assessment or X-Rays as per standard of care
Exclusion Criteria
  1. Subject requires complex repair or anterior meniscectomy.
  2. Subject has a concomitant chondral lesion of the ipsilateral knee in addition to meniscal tear.
  3. Current bilateral knee injury.
  4. Insufficient quantity or quality of bone.
  5. Blood supply limitations and previous infections which may retard healing.
  6. Congenital ligamentous hypermobility defined by Beighton score 4 or 5.
  7. Locked knee or haemarthrosis.
  8. Subjects that are skeletally immature.
  9. Advanced Osteoarthritis; Kellgren Lawrence ≥ 2
  10. Fracture of the lower extremities within 6 months prior to screening.
  11. Previous surgery on the affected knee within 12 months prior to screening.
  12. Sensitivity to silicone, polyester, nylon, FD&C Blue No. 2 dye and beeswax.
  13. Other concomitant disease that would interfere with study outcomes.
  14. Subject is included in a vulnerable population (child, prisoner, etc).
  15. Conditions that tend to limit the patient's ability or willingness to restrict activities, follow directions, or perform online subject assessments during the healing period.
  16. Subject is requesting or receiving Worker's compensation related to the knee injury. -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Partial meniscectomy using the Arthrex NanoscopeArthrex Nanoscope-
Partial meniscectomy using conventional arthroscopy equipmentConventional Arthroscopy without Arthrex Nanoscope-
Primary Outcome Measures
NameTimeMethod
Cost Comparison (TDBC)Operative Visit

Cost comparison using the time-drive activity-based costing (TDABC) study design between NanoScope versus conventional arthroscopy for partial meniscectomy in a traditional OR setting.

Secondary Outcome Measures
NameTimeMethod
International Knee Documentation Committee (IKDC) ScorePre Operative, 2 weeks and 6 weeks post op

The IKDC Questionnaire is a subjective scale that provides patients with an overall function score. The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. The symptoms subscale helps to evaluate things such as pain, stiffness, swelling and giving-way of the knee.

The questions prompt an answer 0-10.

The total score is interpreted as a measure of function with higher scores representing higher levels of function.

Visual Analogue Scale (VAS)Pre Operative, 2 weeks and 6 weeks post op

The visual analog scale for pain is a straight line with one end meaning no pain and the other end meaning the worst pain imaginable. A patient marks a point on the line that matches the amount of pain he or she feels.v

Trial Locations

Locations (1)

Orthopedic Rhode Island

🇺🇸

Warwick, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath